XML 102 R89.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed consolidating financial statements - Condensed Consolidating Statements of Operations (Detail) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Condensed Income Statements Captions [Line Items]        
Dialysis and related lab patient service revenues $ 2,734,065 $ 2,718,403 $ 5,369,217 $ 5,309,477
Less: Provision for uncollectible accounts (10,249) (49,406) (15,712) (23,861)
Net dialysis and related lab patient service revenues 2,723,816 2,668,997 5,353,505 5,285,616
Other revenues 118,889 217,956 232,312 450,781
Total revenues 2,842,705 2,886,953 5,585,817 5,736,397
Operating expenses 2,380,819 2,448,761 4,783,424 4,887,519
Operating income 461,886 438,192 802,393 848,878
Debt expense (143,826) (119,692) (275,345) (233,208)
Other income, net 5,643 1,994 12,583 6,576
Income tax expense 75,938 83,868 132,684 154,605
Equity earnings in subsidiaries 0 0 0 0
Net income from continuing operations 247,765 236,626 406,947 467,641
Net income from discontinued operations, net of tax 79,392 69,696 109,697 63,910
Net income 327,157 306,322 516,644 531,551
Less: Net income attributable to noncontrolling interests (53,606) (39,046) (93,804) (85,589)
Net income attributable to DaVita Inc. 273,551 267,276 422,840 445,962
Consolidating adjustments        
Condensed Income Statements Captions [Line Items]        
Dialysis and related lab patient service revenues (61,870) (49,788) (122,568) (97,303)
Less: Provision for uncollectible accounts 0 0 0 0
Net dialysis and related lab patient service revenues (61,870) (49,788) (122,568) (97,303)
Other revenues (240,671) (244,764) (462,844) (483,397)
Total revenues (302,541) (294,552) (585,412) (580,700)
Operating expenses (302,541) (294,552) (585,412) (580,700)
Operating income 0 0 0 0
Debt expense 65,049 62,759 130,323 123,149
Other income, net (108,090) (110,646) (223,055) (218,372)
Income tax expense 0 0 0 0
Equity earnings in subsidiaries (438,621) (393,921) (580,154) (561,090)
Net income from continuing operations (481,662) (441,808) (672,886) (656,313)
Net income from discontinued operations, net of tax 43,041 47,887 92,732 95,223
Net income (438,621) (393,921) (580,154) (561,090)
Less: Net income attributable to noncontrolling interests (53,606) (39,046) (93,804) (85,589)
Net income attributable to DaVita Inc. (492,227) (432,967) (673,958) (646,679)
DaVita Inc. | Reportable Legal Entities        
Condensed Income Statements Captions [Line Items]        
Dialysis and related lab patient service revenues 0 0 0 0
Less: Provision for uncollectible accounts 0 0 0 0
Net dialysis and related lab patient service revenues 0 0 0 0
Other revenues 207,299 205,317 396,135 400,882
Total revenues 207,299 205,317 396,135 400,882
Operating expenses 160,464 145,649 304,123 279,005
Operating income 46,835 59,668 92,012 121,877
Debt expense (144,896) (120,814) (278,491) (235,148)
Other income, net 102,059 105,344 212,257 209,425
Income tax expense 627 13,257 7,653 27,644
Equity earnings in subsidiaries 270,180 236,335 404,715 377,452
Net income from continuing operations 273,551 267,276 422,840 445,962
Net income from discontinued operations, net of tax 0 0 0 0
Net income 273,551 267,276 422,840 445,962
Less: Net income attributable to noncontrolling interests 0 0 0 0
Net income attributable to DaVita Inc. 273,551 267,276 422,840 445,962
Guarantor subsidiaries | Reportable Legal Entities        
Condensed Income Statements Captions [Line Items]        
Dialysis and related lab patient service revenues 1,781,066 1,831,545 3,558,312 3,621,733
Less: Provision for uncollectible accounts (7,246) (27,159) (11,216) (17,531)
Net dialysis and related lab patient service revenues 1,773,820 1,804,386 3,547,096 3,604,202
Other revenues 115,226 214,266 226,367 419,226
Total revenues 1,889,046 2,018,652 3,773,463 4,023,428
Operating expenses 1,673,331 1,850,377 3,333,784 3,641,471
Operating income 215,715 168,275 439,679 381,957
Debt expense (52,762) (52,363) (105,241) (104,560)
Other income, net 2,716 2,856 5,312 5,379
Income tax expense 63,930 40,019 110,474 88,962
Equity earnings in subsidiaries 168,441 157,586 175,439 183,638
Net income from continuing operations 270,180 236,335 404,715 377,452
Net income from discontinued operations, net of tax 0 0 0 0
Net income 270,180 236,335 404,715 377,452
Less: Net income attributable to noncontrolling interests 0 0 0 0
Net income attributable to DaVita Inc. 270,180 236,335 404,715 377,452
Non- Guarantor subsidiaries | Reportable Legal Entities        
Condensed Income Statements Captions [Line Items]        
Dialysis and related lab patient service revenues 1,014,869 936,646 1,933,473 1,785,047
Less: Provision for uncollectible accounts (3,003) (22,247) (4,496) (6,330)
Net dialysis and related lab patient service revenues 1,011,866 914,399 1,928,977 1,778,717
Other revenues 37,035 43,137 72,654 114,070
Total revenues 1,048,901 957,536 2,001,631 1,892,787
Operating expenses 849,565 747,287 1,730,929 1,547,743
Operating income 199,336 210,249 270,702 345,044
Debt expense (11,217) (9,274) (21,936) (16,649)
Other income, net 8,958 4,440 18,069 10,144
Income tax expense 11,381 30,592 14,557 37,999
Equity earnings in subsidiaries 0 0 0 0
Net income from continuing operations 185,696 174,823 252,278 300,540
Net income from discontinued operations, net of tax 36,351 21,809 16,965 (31,313)
Net income 222,047 196,632 269,243 269,227
Less: Net income attributable to noncontrolling interests 0 0 0 0
Net income attributable to DaVita Inc. $ 222,047 $ 196,632 $ 269,243 $ 269,227